nodes	percent_of_prediction	percent_of_DWPC	metapath
Pindolol—ADRB1—dilated cardiomyopathy	0.472	0.543	CbGaD
Pindolol—ADRB2—dilated cardiomyopathy	0.397	0.457	CbGaD
Pindolol—Lethargy—Spironolactone—dilated cardiomyopathy	0.00207	0.0292	CcSEcCtD
Pindolol—Sleep disturbance—Lisinopril—dilated cardiomyopathy	0.00204	0.0287	CcSEcCtD
Pindolol—Cramp muscle—Spironolactone—dilated cardiomyopathy	0.00183	0.0258	CcSEcCtD
Pindolol—Psoriasis—Lisinopril—dilated cardiomyopathy	0.00182	0.0256	CcSEcCtD
Pindolol—Heartburn—Lisinopril—dilated cardiomyopathy	0.00166	0.0234	CcSEcCtD
Pindolol—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.00162	0.0228	CcSEcCtD
Pindolol—Drowsiness—Spironolactone—dilated cardiomyopathy	0.00157	0.0221	CcSEcCtD
Pindolol—Lightheadedness—Furosemide—dilated cardiomyopathy	0.00136	0.0192	CcSEcCtD
Pindolol—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.00118	0.0166	CcSEcCtD
Pindolol—Lethargy—Furosemide—dilated cardiomyopathy	0.00113	0.0159	CcSEcCtD
Pindolol—Wheezing—Lisinopril—dilated cardiomyopathy	0.00111	0.0156	CcSEcCtD
Pindolol—Lightheadedness—Lisinopril—dilated cardiomyopathy	0.00102	0.0144	CcSEcCtD
Pindolol—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.00101	0.0142	CcSEcCtD
Pindolol—Confusional state—Spironolactone—dilated cardiomyopathy	0.00101	0.0142	CcSEcCtD
Pindolol—Cramp muscle—Furosemide—dilated cardiomyopathy	0.000995	0.014	CcSEcCtD
Pindolol—Sleep disorder—Lisinopril—dilated cardiomyopathy	0.000958	0.0135	CcSEcCtD
Pindolol—Somnolence—Spironolactone—dilated cardiomyopathy	0.000888	0.0125	CcSEcCtD
Pindolol—Pollakiuria—Furosemide—dilated cardiomyopathy	0.000883	0.0124	CcSEcCtD
Pindolol—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.000862	0.0122	CcSEcCtD
Pindolol—Drowsiness—Furosemide—dilated cardiomyopathy	0.000852	0.012	CcSEcCtD
Pindolol—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.000823	0.0116	CcSEcCtD
Pindolol—Sweating—Furosemide—dilated cardiomyopathy	0.000817	0.0115	CcSEcCtD
Pindolol—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.000758	0.0107	CcSEcCtD
Pindolol—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.000747	0.0105	CcSEcCtD
Pindolol—Visual impairment—Furosemide—dilated cardiomyopathy	0.000737	0.0104	CcSEcCtD
Pindolol—Tinnitus—Furosemide—dilated cardiomyopathy	0.000713	0.0101	CcSEcCtD
Pindolol—Pruritus—Spironolactone—dilated cardiomyopathy	0.000707	0.00996	CcSEcCtD
Pindolol—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.000705	0.00994	CcSEcCtD
Pindolol—Angiopathy—Furosemide—dilated cardiomyopathy	0.000694	0.00978	CcSEcCtD
Pindolol—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000683	0.00963	CcSEcCtD
Pindolol—Dizziness—Spironolactone—dilated cardiomyopathy	0.00066	0.00931	CcSEcCtD
Pindolol—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.00066	0.00931	CcSEcCtD
Pindolol—Flatulence—Furosemide—dilated cardiomyopathy	0.000656	0.00925	CcSEcCtD
Pindolol—Weight increased—Lisinopril—dilated cardiomyopathy	0.000652	0.0092	CcSEcCtD
Pindolol—Muscle spasms—Furosemide—dilated cardiomyopathy	0.00064	0.00902	CcSEcCtD
Pindolol—Depression—Lisinopril—dilated cardiomyopathy	0.000637	0.00898	CcSEcCtD
Pindolol—Vomiting—Spironolactone—dilated cardiomyopathy	0.000635	0.00895	CcSEcCtD
Pindolol—Rash—Spironolactone—dilated cardiomyopathy	0.00063	0.00888	CcSEcCtD
Pindolol—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000629	0.00887	CcSEcCtD
Pindolol—Headache—Spironolactone—dilated cardiomyopathy	0.000626	0.00882	CcSEcCtD
Pindolol—Sweating—Lisinopril—dilated cardiomyopathy	0.000613	0.00864	CcSEcCtD
Pindolol—Vertigo—Furosemide—dilated cardiomyopathy	0.000598	0.00843	CcSEcCtD
Pindolol—Nausea—Spironolactone—dilated cardiomyopathy	0.000593	0.00836	CcSEcCtD
Pindolol—Bradycardia—Lisinopril—dilated cardiomyopathy	0.000584	0.00823	CcSEcCtD
Pindolol—Practolol—ADRB1—dilated cardiomyopathy	0.000579	0.0546	CrCbGaD
Pindolol—Hallucination—Lisinopril—dilated cardiomyopathy	0.000571	0.00805	CcSEcCtD
Pindolol—Dry mouth—Furosemide—dilated cardiomyopathy	0.000554	0.00781	CcSEcCtD
Pindolol—Levobunolol—ADRB1—dilated cardiomyopathy	0.000549	0.0517	CrCbGaD
Pindolol—Confusional state—Furosemide—dilated cardiomyopathy	0.000548	0.00772	CcSEcCtD
Pindolol—Tinnitus—Lisinopril—dilated cardiomyopathy	0.000535	0.00754	CcSEcCtD
Pindolol—Shock—Furosemide—dilated cardiomyopathy	0.000535	0.00753	CcSEcCtD
Pindolol—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.000533	0.00751	CcSEcCtD
Pindolol—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.000525	0.0074	CcSEcCtD
Pindolol—Metipranolol—ADRB1—dilated cardiomyopathy	0.000524	0.0494	CrCbGaD
Pindolol—Angiopathy—Lisinopril—dilated cardiomyopathy	0.000521	0.00734	CcSEcCtD
Pindolol—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.000517	0.00729	CcSEcCtD
Pindolol—Hypotension—Furosemide—dilated cardiomyopathy	0.000508	0.00716	CcSEcCtD
Pindolol—Mental disorder—Lisinopril—dilated cardiomyopathy	0.000503	0.00709	CcSEcCtD
Pindolol—Flatulence—Lisinopril—dilated cardiomyopathy	0.000492	0.00694	CcSEcCtD
Pindolol—Tension—Lisinopril—dilated cardiomyopathy	0.00049	0.00691	CcSEcCtD
Pindolol—Paraesthesia—Furosemide—dilated cardiomyopathy	0.000488	0.00688	CcSEcCtD
Pindolol—Nervousness—Lisinopril—dilated cardiomyopathy	0.000485	0.00684	CcSEcCtD
Pindolol—Somnolence—Furosemide—dilated cardiomyopathy	0.000483	0.00681	CcSEcCtD
Pindolol—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.00048	0.00677	CcSEcCtD
Pindolol—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.000469	0.00661	CcSEcCtD
Pindolol—Fatigue—Furosemide—dilated cardiomyopathy	0.000468	0.0066	CcSEcCtD
Pindolol—Tremor—Lisinopril—dilated cardiomyopathy	0.000468	0.0066	CcSEcCtD
Pindolol—Carteolol—ADRB1—dilated cardiomyopathy	0.000467	0.044	CrCbGaD
Pindolol—Constipation—Furosemide—dilated cardiomyopathy	0.000465	0.00655	CcSEcCtD
Pindolol—Pain—Furosemide—dilated cardiomyopathy	0.000465	0.00655	CcSEcCtD
Pindolol—Levobunolol—ADRB2—dilated cardiomyopathy	0.000462	0.0435	CrCbGaD
Pindolol—Vertigo—Lisinopril—dilated cardiomyopathy	0.000449	0.00633	CcSEcCtD
Pindolol—Syncope—Lisinopril—dilated cardiomyopathy	0.000448	0.00631	CcSEcCtD
Pindolol—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000448	0.00631	CcSEcCtD
Pindolol—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000444	0.00626	CcSEcCtD
Pindolol—Palpitations—Lisinopril—dilated cardiomyopathy	0.000441	0.00622	CcSEcCtD
Pindolol—Metipranolol—ADRB2—dilated cardiomyopathy	0.00044	0.0415	CrCbGaD
Pindolol—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.000439	0.00619	CcSEcCtD
Pindolol—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00043	0.00605	CcSEcCtD
Pindolol—Arthralgia—Lisinopril—dilated cardiomyopathy	0.000425	0.00599	CcSEcCtD
Pindolol—Chest pain—Lisinopril—dilated cardiomyopathy	0.000425	0.00599	CcSEcCtD
Pindolol—Myalgia—Lisinopril—dilated cardiomyopathy	0.000425	0.00599	CcSEcCtD
Pindolol—Anxiety—Lisinopril—dilated cardiomyopathy	0.000424	0.00597	CcSEcCtD
Pindolol—Esmolol—ADRB1—dilated cardiomyopathy	0.000416	0.0392	CrCbGaD
Pindolol—Nadolol—ADRB1—dilated cardiomyopathy	0.000416	0.0392	CrCbGaD
Pindolol—Dry mouth—Lisinopril—dilated cardiomyopathy	0.000416	0.00586	CcSEcCtD
Pindolol—Confusional state—Lisinopril—dilated cardiomyopathy	0.000411	0.00579	CcSEcCtD
Pindolol—Oedema—Lisinopril—dilated cardiomyopathy	0.000408	0.00575	CcSEcCtD
Pindolol—Shock—Lisinopril—dilated cardiomyopathy	0.000401	0.00565	CcSEcCtD
Pindolol—Tachycardia—Lisinopril—dilated cardiomyopathy	0.000398	0.00561	CcSEcCtD
Pindolol—Bupranolol—ADRB1—dilated cardiomyopathy	0.000397	0.0374	CrCbGaD
Pindolol—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000394	0.00555	CcSEcCtD
Pindolol—Carteolol—ADRB2—dilated cardiomyopathy	0.000393	0.037	CrCbGaD
Pindolol—Asthenia—Furosemide—dilated cardiomyopathy	0.00039	0.00549	CcSEcCtD
Pindolol—Pruritus—Furosemide—dilated cardiomyopathy	0.000384	0.00542	CcSEcCtD
Pindolol—Hypotension—Lisinopril—dilated cardiomyopathy	0.000381	0.00537	CcSEcCtD
Pindolol—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000372	0.00524	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000371	0.00523	CcSEcCtD
Pindolol—Insomnia—Lisinopril—dilated cardiomyopathy	0.000369	0.0052	CcSEcCtD
Pindolol—Betaxolol—ADRB1—dilated cardiomyopathy	0.000366	0.0345	CrCbGaD
Pindolol—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000366	0.00516	CcSEcCtD
Pindolol—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000363	0.00512	CcSEcCtD
Pindolol—Atenolol—ADRB1—dilated cardiomyopathy	0.000363	0.0342	CrCbGaD
Pindolol—Somnolence—Lisinopril—dilated cardiomyopathy	0.000362	0.00511	CcSEcCtD
Pindolol—Dizziness—Furosemide—dilated cardiomyopathy	0.000359	0.00506	CcSEcCtD
Pindolol—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000359	0.00506	CcSEcCtD
Pindolol—Bisoprolol—ADRB1—dilated cardiomyopathy	0.000354	0.0333	CrCbGaD
Pindolol—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000352	0.00496	CcSEcCtD
Pindolol—Fatigue—Lisinopril—dilated cardiomyopathy	0.000351	0.00495	CcSEcCtD
Pindolol—Esmolol—ADRB2—dilated cardiomyopathy	0.00035	0.033	CrCbGaD
Pindolol—Nadolol—ADRB2—dilated cardiomyopathy	0.00035	0.033	CrCbGaD
Pindolol—Pain—Lisinopril—dilated cardiomyopathy	0.000349	0.00491	CcSEcCtD
Pindolol—Constipation—Lisinopril—dilated cardiomyopathy	0.000349	0.00491	CcSEcCtD
Pindolol—Vomiting—Furosemide—dilated cardiomyopathy	0.000345	0.00487	CcSEcCtD
Pindolol—Rash—Furosemide—dilated cardiomyopathy	0.000343	0.00483	CcSEcCtD
Pindolol—Dermatitis—Furosemide—dilated cardiomyopathy	0.000342	0.00482	CcSEcCtD
Pindolol—Headache—Furosemide—dilated cardiomyopathy	0.00034	0.0048	CcSEcCtD
Pindolol—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000336	0.00473	CcSEcCtD
Pindolol—Acebutolol—ADRB1—dilated cardiomyopathy	0.000335	0.0316	CrCbGaD
Pindolol—Bupranolol—ADRB2—dilated cardiomyopathy	0.000334	0.0315	CrCbGaD
Pindolol—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000333	0.0047	CcSEcCtD
Pindolol—Oxprenolol—ADRB1—dilated cardiomyopathy	0.000333	0.0313	CrCbGaD
Pindolol—Nausea—Furosemide—dilated cardiomyopathy	0.000323	0.00455	CcSEcCtD
Pindolol—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000322	0.00454	CcSEcCtD
Pindolol—Betaxolol—ADRB2—dilated cardiomyopathy	0.000308	0.029	CrCbGaD
Pindolol—Atenolol—ADRB2—dilated cardiomyopathy	0.000305	0.0288	CrCbGaD
Pindolol—Alprenolol—ADRB1—dilated cardiomyopathy	0.000304	0.0287	CrCbGaD
Pindolol—Bisoprolol—ADRB2—dilated cardiomyopathy	0.000298	0.028	CrCbGaD
Pindolol—Asthenia—Lisinopril—dilated cardiomyopathy	0.000292	0.00412	CcSEcCtD
Pindolol—Pruritus—Lisinopril—dilated cardiomyopathy	0.000288	0.00407	CcSEcCtD
Pindolol—Metoprolol—ADRB1—dilated cardiomyopathy	0.000283	0.0267	CrCbGaD
Pindolol—Acebutolol—ADRB2—dilated cardiomyopathy	0.000282	0.0266	CrCbGaD
Pindolol—Oxprenolol—ADRB2—dilated cardiomyopathy	0.00028	0.0264	CrCbGaD
Pindolol—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000279	0.00393	CcSEcCtD
Pindolol—Dizziness—Lisinopril—dilated cardiomyopathy	0.00027	0.0038	CcSEcCtD
Pindolol—Vomiting—Lisinopril—dilated cardiomyopathy	0.000259	0.00365	CcSEcCtD
Pindolol—Rash—Lisinopril—dilated cardiomyopathy	0.000257	0.00362	CcSEcCtD
Pindolol—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000257	0.00362	CcSEcCtD
Pindolol—Alprenolol—ADRB2—dilated cardiomyopathy	0.000256	0.0241	CrCbGaD
Pindolol—Headache—Lisinopril—dilated cardiomyopathy	0.000255	0.0036	CcSEcCtD
Pindolol—Nausea—Lisinopril—dilated cardiomyopathy	0.000242	0.00341	CcSEcCtD
Pindolol—Metoprolol—ADRB2—dilated cardiomyopathy	0.000238	0.0224	CrCbGaD
Pindolol—Isoprenaline—ADRB1—dilated cardiomyopathy	0.000201	0.0189	CrCbGaD
Pindolol—HTR1B—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.000201	0.00399	CbGpPWpGaD
Pindolol—HTR1B—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.000201	0.00399	CbGpPWpGaD
Pindolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000199	0.00395	CbGpPWpGaD
Pindolol—ADRB1—G alpha (s) signalling events—ADRB2—dilated cardiomyopathy	0.000194	0.00386	CbGpPWpGaD
Pindolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000193	0.00383	CbGpPWpGaD
Pindolol—ADRB3—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000192	0.00382	CbGpPWpGaD
Pindolol—HTR1B—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.000186	0.00371	CbGpPWpGaD
Pindolol—HTR1B—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.000186	0.0037	CbGpPWpGaD
Pindolol—ADRB2—Arf6 signaling events—EGFR—dilated cardiomyopathy	0.000185	0.00367	CbGpPWpGaD
Pindolol—ADRB3—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000182	0.00362	CbGpPWpGaD
Pindolol—HTR1B—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.000173	0.00344	CbGpPWpGaD
Pindolol—ADRB1—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	0.000171	0.0034	CbGpPWpGaD
Pindolol—Isoprenaline—ADRB2—dilated cardiomyopathy	0.000169	0.0159	CrCbGaD
Pindolol—ADRB1—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	0.000168	0.00334	CbGpPWpGaD
Pindolol—HTR1B—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000168	0.00333	CbGpPWpGaD
Pindolol—ADRB2—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	0.000167	0.00332	CbGpPWpGaD
Pindolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000164	0.00327	CbGpPWpGaD
Pindolol—ADRB3—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000163	0.00324	CbGpPWpGaD
Pindolol—ADRB3—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000163	0.00324	CbGpPWpGaD
Pindolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000159	0.00317	CbGpPWpGaD
Pindolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000159	0.00317	CbGpPWpGaD
Pindolol—HTR1A—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.000158	0.00313	CbGpPWpGaD
Pindolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000156	0.0031	CbGpPWpGaD
Pindolol—HTR1A—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.000153	0.00304	CbGpPWpGaD
Pindolol—HTR1A—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.000153	0.00304	CbGpPWpGaD
Pindolol—ADRB3—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000151	0.00301	CbGpPWpGaD
Pindolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000148	0.00295	CbGpPWpGaD
Pindolol—ADRB1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.000148	0.00295	CbGpPWpGaD
Pindolol—ADRB3—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000147	0.00292	CbGpPWpGaD
Pindolol—ADRB2—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.000145	0.00288	CbGpPWpGaD
Pindolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000144	0.00285	CbGpPWpGaD
Pindolol—HTR1B—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000143	0.00285	CbGpPWpGaD
Pindolol—Propranolol—ADRB1—dilated cardiomyopathy	0.000143	0.0135	CrCbGaD
Pindolol—HTR1A—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.000142	0.00282	CbGpPWpGaD
Pindolol—HTR1A—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.000142	0.00282	CbGpPWpGaD
Pindolol—ADRB1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.000138	0.00274	CbGpPWpGaD
Pindolol—HTR1A—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.000137	0.00272	CbGpPWpGaD
Pindolol—HTR1B—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000136	0.0027	CbGpPWpGaD
Pindolol—ADRB2—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.000135	0.00268	CbGpPWpGaD
Pindolol—HTR1A—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.000132	0.00262	CbGpPWpGaD
Pindolol—ADRB2—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000131	0.0026	CbGpPWpGaD
Pindolol—HTR1A—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000128	0.00254	CbGpPWpGaD
Pindolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000127	0.00252	CbGpPWpGaD
Pindolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000127	0.00252	CbGpPWpGaD
Pindolol—ADRB3—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000125	0.00249	CbGpPWpGaD
Pindolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000124	0.00247	CbGpPWpGaD
Pindolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000124	0.00247	CbGpPWpGaD
Pindolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000123	0.00244	CbGpPWpGaD
Pindolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000121	0.00241	CbGpPWpGaD
Pindolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000121	0.00241	CbGpPWpGaD
Pindolol—HTR1B—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000121	0.00241	CbGpPWpGaD
Pindolol—HTR1B—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000121	0.00241	CbGpPWpGaD
Pindolol—Propranolol—ADRB2—dilated cardiomyopathy	0.00012	0.0113	CrCbGaD
Pindolol—ADRB3—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000119	0.00236	CbGpPWpGaD
Pindolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000118	0.00235	CbGpPWpGaD
Pindolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000116	0.00231	CbGpPWpGaD
Pindolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000116	0.0023	CbGpPWpGaD
Pindolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000115	0.0023	CbGpPWpGaD
Pindolol—ADRB1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000114	0.00227	CbGpPWpGaD
Pindolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000113	0.00224	CbGpPWpGaD
Pindolol—HTR1B—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000113	0.00224	CbGpPWpGaD
Pindolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000112	0.00222	CbGpPWpGaD
Pindolol—ADRB2—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000111	0.00222	CbGpPWpGaD
Pindolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000109	0.00217	CbGpPWpGaD
Pindolol—HTR1B—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000109	0.00217	CbGpPWpGaD
Pindolol—HTR1A—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000109	0.00217	CbGpPWpGaD
Pindolol—HTR1B—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000109	0.00216	CbGpPWpGaD
Pindolol—ADRB1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000108	0.00215	CbGpPWpGaD
Pindolol—HTR1A—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000103	0.00206	CbGpPWpGaD
Pindolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	9.76e-05	0.00194	CbGpPWpGaD
Pindolol—ADRB1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	9.67e-05	0.00192	CbGpPWpGaD
Pindolol—ADRB1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	9.67e-05	0.00192	CbGpPWpGaD
Pindolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	9.55e-05	0.0019	CbGpPWpGaD
Pindolol—ADRB2—GPCR ligand binding—AGTR2—dilated cardiomyopathy	9.46e-05	0.00188	CbGpPWpGaD
Pindolol—ADRB2—GPCR ligand binding—CXCL2—dilated cardiomyopathy	9.46e-05	0.00188	CbGpPWpGaD
Pindolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	9.34e-05	0.00186	CbGpPWpGaD
Pindolol—HTR1B—GPCR ligand binding—AGTR1—dilated cardiomyopathy	9.34e-05	0.00186	CbGpPWpGaD
Pindolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	9.26e-05	0.00184	CbGpPWpGaD
Pindolol—HTR1A—GPCR ligand binding—CXCL2—dilated cardiomyopathy	9.25e-05	0.00184	CbGpPWpGaD
Pindolol—HTR1A—GPCR ligand binding—AGTR2—dilated cardiomyopathy	9.25e-05	0.00184	CbGpPWpGaD
Pindolol—ADRB3—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	9.21e-05	0.00183	CbGpPWpGaD
Pindolol—ADRB3—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	9.21e-05	0.00183	CbGpPWpGaD
Pindolol—ADRB1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	8.99e-05	0.00179	CbGpPWpGaD
Pindolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	8.86e-05	0.00176	CbGpPWpGaD
Pindolol—HTR1B—GPCR ligand binding—ADRB2—dilated cardiomyopathy	8.86e-05	0.00176	CbGpPWpGaD
Pindolol—ADRB3—GPCR ligand binding—AGT—dilated cardiomyopathy	8.81e-05	0.00175	CbGpPWpGaD
Pindolol—ADRB2—GPCR ligand binding—CXCR3—dilated cardiomyopathy	8.79e-05	0.00175	CbGpPWpGaD
Pindolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	8.63e-05	0.00172	CbGpPWpGaD
Pindolol—HTR1A—GPCR ligand binding—CXCR3—dilated cardiomyopathy	8.6e-05	0.00171	CbGpPWpGaD
Pindolol—ADRB3—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	8.56e-05	0.0017	CbGpPWpGaD
Pindolol—ADRB2—GPCR ligand binding—ADRB1—dilated cardiomyopathy	8.52e-05	0.00169	CbGpPWpGaD
Pindolol—ADRB3—Signaling by GPCR—AGTR2—dilated cardiomyopathy	8.36e-05	0.00166	CbGpPWpGaD
Pindolol—ADRB3—Signaling by GPCR—CXCL2—dilated cardiomyopathy	8.36e-05	0.00166	CbGpPWpGaD
Pindolol—HTR1A—GPCR ligand binding—ADRB1—dilated cardiomyopathy	8.33e-05	0.00166	CbGpPWpGaD
Pindolol—ADRB3—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	8.29e-05	0.00165	CbGpPWpGaD
Pindolol—HTR1A—G alpha (i) signalling events—AGT—dilated cardiomyopathy	8.27e-05	0.00164	CbGpPWpGaD
Pindolol—ADRB3—Signaling by GPCR—CXCR3—dilated cardiomyopathy	7.77e-05	0.00155	CbGpPWpGaD
Pindolol—ADRB3—Signaling by GPCR—ADRB1—dilated cardiomyopathy	7.53e-05	0.0015	CbGpPWpGaD
Pindolol—ADRB1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	7.44e-05	0.00148	CbGpPWpGaD
Pindolol—ADRB2—GPCR ligand binding—AGTR1—dilated cardiomyopathy	7.27e-05	0.00145	CbGpPWpGaD
Pindolol—HTR1A—GPCR ligand binding—AGTR1—dilated cardiomyopathy	7.11e-05	0.00141	CbGpPWpGaD
Pindolol—ADRB3—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	7.08e-05	0.00141	CbGpPWpGaD
Pindolol—ADRB1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	7.05e-05	0.0014	CbGpPWpGaD
Pindolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	6.87e-05	0.00137	CbGpPWpGaD
Pindolol—HTR1B—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	6.86e-05	0.00136	CbGpPWpGaD
Pindolol—HTR1B—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	6.86e-05	0.00136	CbGpPWpGaD
Pindolol—HTR1A—GPCR ligand binding—ADRB2—dilated cardiomyopathy	6.75e-05	0.00134	CbGpPWpGaD
Pindolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	6.72e-05	0.00134	CbGpPWpGaD
Pindolol—ADRB3—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	6.72e-05	0.00134	CbGpPWpGaD
Pindolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	6.57e-05	0.00131	CbGpPWpGaD
Pindolol—HTR1B—GPCR ligand binding—AGT—dilated cardiomyopathy	6.57e-05	0.00131	CbGpPWpGaD
Pindolol—ADRB3—Signaling by GPCR—AGTR1—dilated cardiomyopathy	6.43e-05	0.00128	CbGpPWpGaD
Pindolol—HTR1B—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	6.38e-05	0.00127	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—AGTR2—dilated cardiomyopathy	6.23e-05	0.00124	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—CXCL2—dilated cardiomyopathy	6.23e-05	0.00124	CbGpPWpGaD
Pindolol—HTR1B—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	6.18e-05	0.00123	CbGpPWpGaD
Pindolol—ADRB3—Signaling by GPCR—ADRB2—dilated cardiomyopathy	6.1e-05	0.00121	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—CXCR3—dilated cardiomyopathy	5.79e-05	0.00115	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—ADRB1—dilated cardiomyopathy	5.61e-05	0.00112	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—PSEN2—dilated cardiomyopathy	5.56e-05	0.00111	CbGpPWpGaD
Pindolol—ADRB1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	5.46e-05	0.00109	CbGpPWpGaD
Pindolol—ADRB1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	5.46e-05	0.00109	CbGpPWpGaD
Pindolol—ADRB2—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	5.35e-05	0.00106	CbGpPWpGaD
Pindolol—ADRB2—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	5.35e-05	0.00106	CbGpPWpGaD
Pindolol—HTR1B—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	5.28e-05	0.00105	CbGpPWpGaD
Pindolol—ADRB1—GPCR ligand binding—AGT—dilated cardiomyopathy	5.23e-05	0.00104	CbGpPWpGaD
Pindolol—HTR1A—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	5.23e-05	0.00104	CbGpPWpGaD
Pindolol—HTR1A—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	5.23e-05	0.00104	CbGpPWpGaD
Pindolol—ADRB3—GPCR downstream signaling—RAC1—dilated cardiomyopathy	5.21e-05	0.00104	CbGpPWpGaD
Pindolol—HTR1A—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	5.2e-05	0.00103	CbGpPWpGaD
Pindolol—ADRB2—GPCR ligand binding—AGT—dilated cardiomyopathy	5.12e-05	0.00102	CbGpPWpGaD
Pindolol—ADRB1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	5.08e-05	0.00101	CbGpPWpGaD
Pindolol—HTR1B—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	5.01e-05	0.000995	CbGpPWpGaD
Pindolol—HTR1A—GPCR ligand binding—AGT—dilated cardiomyopathy	5e-05	0.000995	CbGpPWpGaD
Pindolol—ADRB3—GPCR downstream signaling—AGT—dilated cardiomyopathy	4.98e-05	0.00099	CbGpPWpGaD
Pindolol—ADRB2—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	4.97e-05	0.000988	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	4.96e-05	0.000987	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	4.96e-05	0.000987	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—CXCL2—dilated cardiomyopathy	4.94e-05	0.000982	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—AGTR2—dilated cardiomyopathy	4.94e-05	0.000982	CbGpPWpGaD
Pindolol—HTR1A—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	4.86e-05	0.000966	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—AGTR2—dilated cardiomyopathy	4.85e-05	0.000965	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—CXCL2—dilated cardiomyopathy	4.85e-05	0.000965	CbGpPWpGaD
Pindolol—ADRB2—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	4.81e-05	0.000957	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—AGTR1—dilated cardiomyopathy	4.79e-05	0.000953	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	4.75e-05	0.000944	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	4.75e-05	0.000944	CbGpPWpGaD
Pindolol—ADRB3—Signaling by GPCR—RAC1—dilated cardiomyopathy	4.73e-05	0.000941	CbGpPWpGaD
Pindolol—HTR1A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	4.71e-05	0.000936	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	4.61e-05	0.000917	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—CXCR3—dilated cardiomyopathy	4.59e-05	0.000913	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—ANKRD1—dilated cardiomyopathy	4.59e-05	0.000912	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—ADRB2—dilated cardiomyopathy	4.55e-05	0.000904	CbGpPWpGaD
Pindolol—ADRB3—Signaling by GPCR—AGT—dilated cardiomyopathy	4.52e-05	0.000899	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	4.51e-05	0.000897	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—ADRB1—dilated cardiomyopathy	4.45e-05	0.000884	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	4.41e-05	0.000877	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	4.37e-05	0.000869	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—TAZ—dilated cardiomyopathy	4.31e-05	0.000858	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	4.27e-05	0.00085	CbGpPWpGaD
Pindolol—ADRB1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	4.2e-05	0.000835	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—PSEN2—dilated cardiomyopathy	4.15e-05	0.000824	CbGpPWpGaD
Pindolol—ADRB2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	4.11e-05	0.000817	CbGpPWpGaD
Pindolol—HTR1A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	4.02e-05	0.000799	CbGpPWpGaD
Pindolol—ADRB1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	3.99e-05	0.000793	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—SDHA—dilated cardiomyopathy	3.9e-05	0.000776	CbGpPWpGaD
Pindolol—HTR1B—GPCR downstream signaling—RAC1—dilated cardiomyopathy	3.89e-05	0.000773	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	3.82e-05	0.000759	CbGpPWpGaD
Pindolol—HTR1A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	3.81e-05	0.000758	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—AGTR1—dilated cardiomyopathy	3.8e-05	0.000755	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	3.73e-05	0.000742	CbGpPWpGaD
Pindolol—HTR1B—GPCR downstream signaling—AGT—dilated cardiomyopathy	3.71e-05	0.000738	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—CXCL2—dilated cardiomyopathy	3.68e-05	0.000732	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—AGTR2—dilated cardiomyopathy	3.68e-05	0.000732	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	3.65e-05	0.000726	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	3.62e-05	0.00072	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—ADRB2—dilated cardiomyopathy	3.6e-05	0.000716	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—RAC1—dilated cardiomyopathy	3.53e-05	0.000702	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	3.46e-05	0.000688	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—CXCR3—dilated cardiomyopathy	3.42e-05	0.00068	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—AGT—dilated cardiomyopathy	3.37e-05	0.00067	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—ADRB1—dilated cardiomyopathy	3.31e-05	0.000659	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—PSEN2—dilated cardiomyopathy	3.3e-05	0.000656	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—PSEN2—dilated cardiomyopathy	3.23e-05	0.000642	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—PSEN2—dilated cardiomyopathy	3.16e-05	0.000628	CbGpPWpGaD
Pindolol—ADRB3—Signaling by GPCR—RAF1—dilated cardiomyopathy	3.14e-05	0.000624	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	3.1e-05	0.000616	CbGpPWpGaD
Pindolol—ADRB1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	3.09e-05	0.000615	CbGpPWpGaD
Pindolol—ADRB2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	3.03e-05	0.000602	CbGpPWpGaD
Pindolol—HTR1A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	2.96e-05	0.000589	CbGpPWpGaD
Pindolol—ADRB1—GPCR downstream signaling—AGT—dilated cardiomyopathy	2.96e-05	0.000588	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—CXCL2—dilated cardiomyopathy	2.93e-05	0.000583	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—AGTR2—dilated cardiomyopathy	2.93e-05	0.000583	CbGpPWpGaD
Pindolol—ADRB2—GPCR downstream signaling—AGT—dilated cardiomyopathy	2.89e-05	0.000575	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—CXCL2—dilated cardiomyopathy	2.87e-05	0.00057	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—AGTR2—dilated cardiomyopathy	2.87e-05	0.00057	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.83e-05	0.000563	CbGpPWpGaD
Pindolol—HTR1A—GPCR downstream signaling—AGT—dilated cardiomyopathy	2.83e-05	0.000562	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—RAC1—dilated cardiomyopathy	2.81e-05	0.000559	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—CXCL2—dilated cardiomyopathy	2.8e-05	0.000557	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—AGTR2—dilated cardiomyopathy	2.8e-05	0.000557	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—RAC1—dilated cardiomyopathy	2.8e-05	0.000556	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—RAC1—dilated cardiomyopathy	2.75e-05	0.000547	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—CXCR3—dilated cardiomyopathy	2.73e-05	0.000542	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—RAC1—dilated cardiomyopathy	2.69e-05	0.000534	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—AGT—dilated cardiomyopathy	2.68e-05	0.000534	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.68e-05	0.000534	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—AGT—dilated cardiomyopathy	2.67e-05	0.000531	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—CXCR3—dilated cardiomyopathy	2.67e-05	0.00053	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—AGT—dilated cardiomyopathy	2.63e-05	0.000522	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—CXCR3—dilated cardiomyopathy	2.61e-05	0.000518	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—ADRB1—dilated cardiomyopathy	2.58e-05	0.000513	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—AGT—dilated cardiomyopathy	2.57e-05	0.000511	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—ADRB1—dilated cardiomyopathy	2.52e-05	0.000502	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.34e-05	0.000465	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.31e-05	0.000459	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.25e-05	0.000448	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.2e-05	0.000438	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.16e-05	0.000429	CbGpPWpGaD
Pindolol—ADRB3—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.15e-05	0.000428	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.14e-05	0.000425	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—RAC1—dilated cardiomyopathy	2.08e-05	0.000414	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.05e-05	0.000407	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—AGT—dilated cardiomyopathy	1.99e-05	0.000396	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.86e-05	0.00037	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—RAF1—dilated cardiomyopathy	1.85e-05	0.000369	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.84e-05	0.000365	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.82e-05	0.000362	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.8e-05	0.000357	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.78e-05	0.000354	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.76e-05	0.000349	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—RAC1—dilated cardiomyopathy	1.66e-05	0.00033	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—RAC1—dilated cardiomyopathy	1.62e-05	0.000323	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.6e-05	0.000319	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—RAC1—dilated cardiomyopathy	1.59e-05	0.000316	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—AGT—dilated cardiomyopathy	1.59e-05	0.000315	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—AGT—dilated cardiomyopathy	1.55e-05	0.000309	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—AGT—dilated cardiomyopathy	1.52e-05	0.000302	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—RAF1—dilated cardiomyopathy	1.38e-05	0.000275	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.28e-05	0.000254	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—EGFR—dilated cardiomyopathy	1.27e-05	0.000253	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.25e-05	0.000249	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.22e-05	0.000243	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—RAF1—dilated cardiomyopathy	1.1e-05	0.000219	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—RAF1—dilated cardiomyopathy	1.08e-05	0.000214	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	1.06e-05	0.000211	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—RAF1—dilated cardiomyopathy	1.05e-05	0.000209	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	1.03e-05	0.000205	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—EGFR—dilated cardiomyopathy	9.48e-06	0.000188	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	9.29e-06	0.000185	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—EGFR—dilated cardiomyopathy	7.55e-06	0.00015	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—EGFR—dilated cardiomyopathy	7.38e-06	0.000147	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—EGFR—dilated cardiomyopathy	7.22e-06	0.000144	CbGpPWpGaD
